Authors: GERHARTZ HH ZWIERZINA H SUCIU S WALTHER J DARDENNE M NEUWIRTOVA R FENAUX P BEKSAC M HAROUSSEAU JL LOUWAGIE A THYSS A FIERE D COIFFIER B BAUMELOU F LABAR B SOLBU G WILLEMZE R

Citation: Hh. Gerhartz et al., RANDOMIZED 3-ARM PHASE-III STUDY OF INTERLEUKIN-3 (IL-3), OR GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS AN ADJUVANT TO LOW-DOSES OF CYTOSINE-ARABINOSIDE (LD-ARAC) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (HR-MDS)/, Blood, 90(10), 1997, pp. 370-370